RNF43 and cholangiocarcinoma: In vitro studies have shown that RNF43 expression levels are very low in different CCA cell lines, in which its experimentally induced expression attenuates β-catenin nuclear translocation, indicating that RNF43 is essential to prevent aberrant activation of the Wnt/β-catenin pathway [61].